期刊文献+

SARS-CoV-2 non-structural protein 13 (nspl3) hijacks host deubiquitinase USP13 and counteracts host antiviral immune response 被引量:2

原文传递
导出
摘要 Dear Editor,COVID-19(Coronavirus Disease-2019),a respiratory disease caused by the novel virus strain,SARS-CoV-2(severe acute respiratory syndrome coronavirus 2),an enveloped,positive-sense,single-stranded RNA betacoronavirus of the family Corona-viridae,has spread worldwide.1 Notably,SARS-CoV-2 infection led to poor induction of typeⅠ interferon response,and the impaired type Ⅰ IFN responses have been shown to be associated with severe COVID-19 disease.2 However,molecular mechanisms by which SARS-CoV-2 suppresses type Ⅰ IFN production,and how host cells respond to the inhibition of type Ⅰ IFN response during SARS-CoV-2 infection,remain largely unknown.
出处 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2021年第4期1107-1109,共3页 信号转导与靶向治疗(英文)
基金 This work was supported by funding from NIH ROI AG047156,ROI All 12844&R01 AI147394(J.S.),and CA 203971(ZL) This study was partially funded by the Fraternal Order of Eagles Cancer Research Fund(to M.D.)grant number FP00089365.
  • 相关文献

参考文献1

共引文献2546

同被引文献5

引证文献2

二级引证文献1

  • 1孟颂东.导读[J].生物工程学报,2024,40(2).

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部